We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-11.88%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$15.5B
(-14%)
Cap. Flow
+$483M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
4,137
New
391
Increased
1,950
Reduced
1,291
Closed
279
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$385M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$370M |
| 3 |
Linde
LIN
|
+$309M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$231M |
| 5 |
Alibaba
BABA
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 3 |
Thomson Reuters
TRI
|
+$802M |
| 4 |
UGAZ
VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2
UGAZ
|
+$312M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$266M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.03% |
| 2 | Technology | 10.74% |
| 3 | Healthcare | 9.35% |
| 4 | Industrials | 6.72% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Gorman-Rupp
GRC
$2.14B
| $259K | ﹤0.01% |
7,993
+86
| +1% | +$2.87K |
|
|
SWIR
3452
DELISTED
Sierra Wireless
SWIR
| $259K | ﹤0.01% |
19,307
+2,714
| +16% | +$45.3K |
|
|
ALLK
3453
DELISTED
Allakos
ALLK
| $258K | ﹤0.01% |
+4,928
| New | +$247K |
|
|
APLS
3454
DELISTED
Apellis Pharmaceuticals
APLS
| $258K | ﹤0.01% |
19,556
+5,987
| +44% | +$91.9K |
|
|
FPRX
3455
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $258K | ﹤0.01% |
27,787
+4,666
| +20% | +$55.5K |
|
3456
Global Indemnity Group
GBLI
$402M
| $257K | ﹤0.01% |
7,080
+1,082
| +18% | +$37.9K |
|
|
CTRL
3457
DELISTED
Control4 Corporation
CTRL
| $257K | ﹤0.01% |
14,601
+2,264
| +18% | +$53.6K |
|
3458
Comscore
SCOR
$106M
| $256K | ﹤0.01% |
+888
| New | +$287K |
|
|
ITCI
3459
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $256K | ﹤0.01% |
22,454
+577
| +3% | +$9.31K |
|
|
OMN
3460
DELISTED
OMNOVA Solutions Inc.
OMN
| $256K | ﹤0.01% |
34,921
+6,771
| +24% | +$54.5K |
|
3461
Tilray
TLRY
$618M
| $252K | ﹤0.01% |
+357
| New | +$392K |
|
|
FRGI
3462
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $252K | ﹤0.01% |
16,228
-3,181
| -16% | -$69.3K |
|
|
BFX
3463
DELISTED
BowFlex Inc.
BFX
| $249K | ﹤0.01% |
22,900
+4,564
| +25% | +$57.1K |
|
|
RTL
3464
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $249K | ﹤0.01% |
+18,693
| New | +$257K |
|
|
RC
3465
Ready Capital
RC
$258M
| $247K | ﹤0.01% |
17,849
+7,766
| +77% | +$117K |
|
3466
OneSpan
OSPN
$574M
| $246K | ﹤0.01% |
19,024
+3,992
| +27% | +$64.9K |
|
3467
Aclaris Therapeutics
ACRS
$726M
| $245K | ﹤0.01% |
33,306
+9,849
| +42% | +$102K |
|
3468
McEwen Inc
MUX
$1.03B
| $245K | ﹤0.01% |
13,502
-165,946
| -92% | -$3.21M |
|
3469
Republic Bancorp
RBCAA
$1.95B
| $245K | ﹤0.01% |
6,315
-81
| -1% | -$3.48K |
|
|
ALTA
3470
DELISTED
Altabancorp
ALTA
| $245K | ﹤0.01% |
+8,148
| New | +$260K |
|
3471
CALL
Delek US
DK
$4.16B
| $244K | ﹤0.01% |
7,500
-192,500
| -96% | -$7.28M |
|
3472
Globalstar
GSAT
$10.7B
| $244K | ﹤0.01% |
25,380
+5
| +0% | +$30 |
|
|
CNCE
3473
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $244K | ﹤0.01% |
19,505
+988
| +5% | +$13.6K |
|
|
CARO
3474
DELISTED
Carolina Financial Corp.
CARO
| $244K | ﹤0.01% |
8,206
+321
| +4% | +$10.7K |
|
3475
Entravision Communication
EVC
$1.03B
| $242K | ﹤0.01% |
83,167
+7,745
| +10% | +$30.3K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2018 Portfolio in Review
As of Q4 2018, Credit Suisse held 4,137 positions worth $96.1B, down 14% from $112B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse's Q4 2018 filing shows 391 new, 1,950 increased, 1,291 reduced and 279 closed positions. Its largest new stake was Linde: 1,955,783 shares worth $305M. The largest sale was UnitedHealth, an estimated $1.57B.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- Credit Suisse's largest Q4 2018 buy was Linde: 1,955,783 shares worth $305M.
- Credit Suisse added most to VanEck Gold Miners ETF in Q4 2018, an estimated $385M increase.
- Credit Suisse's biggest Q4 2018 reduction was UnitedHealth, cutting an estimated $1.57B.
- Credit Suisse fully exited Grifois in Q4 2018, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 15% of its $96.1B portfolio in Q4 2018.
- Credit Suisse opened 391 new positions and closed 279 in Q4 2018.
- Credit Suisse's portfolio value fell 14% quarter-over-quarter to $96.1B.
Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.